Karger et al. noted significant variations in the expression levels of these markers, including LGALS3, which encodes the Galectin-3 protein, when comparing thyroid cancer tissues to benign nodules and healthy thyroid tissue [36]. This evidence concerns the gene LGALS3 and neoplasm.